Viewing Study NCT05936346



Ignite Creation Date: 2024-05-06 @ 7:13 PM
Last Modification Date: 2024-10-26 @ 3:02 PM
Study NCT ID: NCT05936346
Status: RECRUITING
Last Update Posted: 2023-09-28
First Post: 2023-06-22

Brief Title: Evaluation of Safety and Tolerability of Salvia Haenkei Extract as a Dietary Supplement Ingredient
Sponsor: IBSA Farmaceutici Italia Srl
Organization: IBSA Farmaceutici Italia Srl

Study Overview

Official Title: Evaluation of Safety and Tolerability of Salvia Haenkei Extract as a Dietary Supplement Ingredient in a Healthy Population A Randomized Open Label Parallel-arm Two-dose Study
Status: RECRUITING
Status Verified Date: 2023-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Evalution of the safety and tolerability of the oral administration of Salvia haenkei in a healthy population
Detailed Description: The aim of the study is to assess the safety and tolerability of the oral administration of Salvia haenkei in a healthy population Furthermore Salvia haenkei has been identified as a potential anti-senescence agent and may counteract aging and aging-associated disorders In this scenario the current study aims also at exploring the effects of this supplementation on muscular and other organ functions kidney liver heart etc and on systemic inflammation and metabolism

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None